Literature DB >> 3898625

Subunit vaccines against enveloped viruses: virosomes, micelles and other protein complexes.

B Morein, K Simons.   

Abstract

The envelope proteins (the peplomers) of enveloped viruses are the components that are important for induction of protective immunity. This article reviews methods and problems of making subunit vaccines of peplomers. In the first section, the solubilization of enveloped viruses with detergent is discussed. The preparation of envelope proteins into defined different physical forms is described, i.e. monomeric and micelle forms and the reconstitution of the protein into lipid vesicles (virosomes). Finally, the preparation of a new type of complex is described (named iscom), which is highly immunogenic. In the following sections the efficacy of the different physical forms are reviewed and it is concluded that monomeric forms must be avoided since they are poorly immunogenic and they may even have a suppressive effect on the immune response. The multimeric micelles, virosomes and iscoms are all immunogenic. The iscom is an interesting new concept that can be used to produce efficient subunit vaccines.

Mesh:

Substances:

Year:  1985        PMID: 3898625     DOI: 10.1016/0264-410x(85)90055-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes.

Authors:  W Jiskoot; T Teerlink; M M Van Hoof; K Bartels; V Kanhai; D J Crommelin; E C Beuvery
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.

Authors:  M Merza; J Söber; B Sundquist; I Toots; B Morein
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 3.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

4.  Protection against lethal measles virus infection in mice by immune-stimulating complexes containing the hemagglutinin or fusion protein.

Authors:  T M Varsanyi; B Morein; A Löve; E Norrby
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

5.  Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein.

Authors:  M Fekadu; J W Sumner; J H Shaddock; D W Sanderlin; G M Baer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 6.  Current state and challenges in developing oral vaccines.

Authors:  Julia E Vela Ramirez; Lindsey A Sharpe; Nicholas A Peppas
Journal:  Adv Drug Deliv Rev       Date:  2017-04-22       Impact factor: 15.470

7.  The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells.

Authors:  M Villacres-Eriksson; M Bergström-Mollaoglu; H Kåberg; K Lövgren; B Morein
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

8.  Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes.

Authors:  M Villacres-Eriksson
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

9.  Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.

Authors:  R Glück; R Mischler; S Brantschen; M Just; B Althaus; S J Cryz
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  Herpes simplex virus type 1-induced hemagglutination: glycoprotein C mediates virus binding to erythrocyte surface heparan sulfate.

Authors:  E Trybala; B Svennerholm; T Bergström; S Olofsson; S Jeansson; J L Goodman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.